Subtopic Deep Dive
N6-Methyladenosine RNA Methylation
Research Guide
What is N6-Methyladenosine RNA Methylation?
N6-methyladenosine (m6A) is the most abundant internal modification on eukaryotic mRNA, dynamically regulated by methyltransferases (METTL3/14), demethylases (FTO/ALKBH5), and reader proteins (YTHDF1-3) that control mRNA stability, translation, and splicing in cancer.
m6A modification influences gene expression post-transcriptionally, with dysregulation linked to cancer proliferation. Key studies show METTL3 overexpression promotes leukemia, glioblastoma, and hepatocellular carcinoma. Over 8,000 papers explore m6A, with top reviews cited >2,000 times each.
Why It Matters
m6A writers like METTL3 drive tumor progression in colorectal carcinoma via IGF2BP2-dependent mechanisms (Li et al., 2019, 852 citations). In leukemia and other cancers, m6A alters mRNA stability to enhance oncogenesis (Deng et al., 2018, 897 citations; Jiang et al., 2021, 2187 citations). Targeting m6A readers such as YTHDF2 offers therapeutic potential, as seen in ocular melanoma where histone lactylation boosts YTHDF2 expression (Yu et al., 2021, 870 citations). These roles position m6A regulators as drug targets in clinical trials.
Key Research Challenges
Detecting m6A site specificity
Mapping exact m6A positions on cancer transcripts remains low-resolution despite MeRIP-seq advances. Variability in reader binding complicates functional assignment (Jiang et al., 2021). Single-cell m6A profiling is nascent for tumor heterogeneity.
Linking m6A to cancer outcomes
Correlating m6A levels with patient survival needs longitudinal data across cancers. Conflicting roles of erasers like FTO in different tumors hinder translation (He et al., 2019). Multi-omics integration is required for causality.
Developing m6A-targeted therapies
Inhibitors for METTL3 show preclinical promise but lack specificity in vivo. Resistance via reader compensation emerges in models (Chen et al., 2019). Clinical biomarkers for m6A dysregulation are undefined.
Essential Papers
The role of m6A modification in the biological functions and diseases
Xiulin Jiang, Baiyang Liu, Zhi Nie et al. · 2021 · Signal Transduction and Targeted Therapy · 2.2K citations
Abstract N 6 -methyladenosine (m6A) is the most prevalent, abundant and conserved internal cotranscriptional modification in eukaryotic RNAs, especially within higher eukaryotic cells. m6A modifica...
Functions of N6-methyladenosine and its role in cancer
Liuer He, Huiyu Li, Anqi Wu et al. · 2019 · Molecular Cancer · 1.5K citations
Abstract N6-methyladenosine (m6A) is methylation that occurs in the N6-position of adenosine, which is the most prevalent internal modification on eukaryotic mRNA. Accumulating evidence suggests th...
The role of m6A RNA methylation in human cancer
Xiaoyu Chen, Jing Zhang, Jin‐Shui Zhu · 2019 · Molecular Cancer · 1.2K citations
The potential role of RNA N6-methyladenosine in Cancer progression
Tianyi Wang, Shan Kong, Mei Tao et al. · 2020 · Molecular Cancer · 1.0K citations
Translation and functional roles of circular RNAs in human cancer
Ming Lei, Guantao Zheng, Qianqian Ning et al. · 2020 · Molecular Cancer · 944 citations
Abstract Circular RNAs (circRNAs) are a new class of non-coding RNAs formed by covalently closed loops through backsplicing. Recent methodologies have enabled in-depth characterization of circRNAs ...
RNA N6-methyladenosine modification in cancers: current status and perspectives
Xiaolan Deng, Rui Su, Hengyou Weng et al. · 2018 · Cell Research · 897 citations
N<sup>6</sup>-methyladenosine (m<sup>6</sup>A), the most abundant internal modification in eukaryotic messenger RNAs (mRNAs), has been shown to play critical roles in various normal bioprocesses su...
Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma
Jie Yu, Peiwei Chai, Minyue Xie et al. · 2021 · Genome biology · 870 citations
Abstract Background Histone lactylation, a metabolic stress-related histone modification, plays an important role in the regulation of gene expression during M1 macrophage polarization. However, th...
Reading Guide
Foundational Papers
Start with Jiang et al. (2021, 2187 citations) for m6A basics and machinery overview, then He et al. (2019, 1495 citations) for cancer-specific functions to build mechanistic foundation.
Recent Advances
Study Yu et al. (2021, 870 citations) on YTHDF2 in ocular melanoma and Li et al. (2019, 852 citations) on METTL3-IGF2BP2 in colorectal cancer for latest oncogenic links.
Core Methods
Core techniques: MeRIP-seq for site mapping (Jiang et al., 2021), Nano-IP for single-molecule detection (Deng et al., 2018), and circRNA-m6A profiling via ribosome profiling (Chen et al., 2019).
How PapersFlow Helps You Research N6-Methyladenosine RNA Methylation
Discover & Search
Research Agent uses searchPapers and exaSearch to find m6A-cancer papers like 'METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism' (Li et al., 2019), then citationGraph reveals 852 citing works on colorectal carcinoma, while findSimilarPapers uncovers related METTL3 studies in leukemia.
Analyze & Verify
Analysis Agent applies readPaperContent to extract m6A writer/eraser mechanisms from Jiang et al. (2021), verifies claims with CoVe chain-of-verification against 10 similar papers, and runs PythonAnalysis for statistical meta-analysis of citation impacts using pandas on m6A overexpression data, graded by GRADE for evidence strength.
Synthesize & Write
Synthesis Agent detects gaps in m6A therapy resistance via contradiction flagging across He et al. (2019) and Deng et al. (2018), while Writing Agent uses latexEditText, latexSyncCitations, and latexCompile to generate a review manuscript with m6A pathway diagrams via exportMermaid.
Use Cases
"Run meta-analysis on METTL3 expression levels across 20 m6A leukemia papers."
Research Agent → searchPapers('METTL3 leukemia m6A') → Analysis Agent → runPythonAnalysis(pandas meta-analysis of effect sizes) → CSV export of survival correlations.
"Draft LaTeX figure of m6A writers/erasers/readers in cancer pathway."
Synthesis Agent → gap detection on pathways from Li et al. (2019) → Writing Agent → latexGenerateFigure + latexSyncCitations + latexCompile → PDF with diagram.
"Find GitHub repos analyzing m6A-seq data from colorectal cancer papers."
Research Agent → paperExtractUrls on Chen et al. (2019) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for m6A site prediction.
Automated Workflows
Deep Research workflow scans 50+ m6A papers via searchPapers → citationGraph → structured report on cancer subtypes with GRADE scores. DeepScan applies 7-step verification: readPaperContent on top 10 (e.g., Jiang 2021) → CoVe → runPythonAnalysis for trend stats. Theorizer generates hypotheses on m6A-circRNA interactions from Yu et al. (2021) and Chen et al. (2019).
Frequently Asked Questions
What defines N6-methyladenosine (m6A) RNA methylation?
m6A is methylation at the N6 position of adenosine, the most prevalent eukaryotic mRNA modification, regulated by METTL3/14 writers, FTO/ALKBH5 erasers, and YTHDF readers (Jiang et al., 2021).
What are key methods for studying m6A in cancer?
MeRIP-seq maps m6A sites, CLIP-seq identifies reader binding, and CRISPR screens validate functions like METTL3 in tumors (Deng et al., 2018; Li et al., 2019).
Which papers are most cited on m6A and cancer?
Top papers include Jiang et al. (2021, 2187 citations) on biological functions, He et al. (2019, 1495 citations) on cancer roles, and Chen et al. (2019, 1161 citations) on human cancer mechanisms.
What open problems exist in m6A cancer research?
Challenges include single-nucleus m6A profiling in tumors, context-specific roles of readers like YTHDF2, and selective METTL3 inhibitors without off-target effects (Yu et al., 2021).
Research RNA modifications and cancer with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching N6-Methyladenosine RNA Methylation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
Part of the RNA modifications and cancer Research Guide